Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.


TSX:HLS - Post by User

Bullboard Posts
Post by valueinvestorron Jan 05, 2012 11:59am
298 Views
Post# 19372751

Automodular Announces Contract Award in the Renewa

Automodular Announces Contract Award in the Renewa

 

AJAX, ONTARIO--(Marketwire - Jan. 5, 2012) - Further to its press release of September 16, 2011 Automodular Corporation (TSX:AM) ("Automodular") reports that it has signed a definitive agreement with Vestas Nacelles A/S to sub-assemble certain wind turbine components for use in Ontario wind projects under the province of Ontario's feed-in-tariff (FIT) program. Vestas Nacelles A/S is a subsidiary of the publicly traded Danish company Vestas Wind Systems A/S, a global leader in the wind industry.

Automodular has secured a facility in Brantford, and, at the peak of the contract, will engage approximately 40 personnel in relation to the contracted work. Work is already underway on the contract which is for a fixed number of units to be assembled over an estimated period of one year. The contract would represent approximately 35% of the Company's gross revenues measured against the Company's gross revenues for the twelve-month period ended September 30, 2011. Approximately 80% of the Company's revenue under the contract relate to the purchase of materials as directed by the customer.

Automodular Corporation is a supplier of sub-assembly, sequencing and transportation services to the automotive industry - Ford's Oakville Assembly Plant and the renewable energy industry -Vestas Nacelles A/S. The Company has three operating facilities and employs approximately 525 people.

This press release contains forward-looking statements that involve a number of risks and uncertainties. Specific forward-looking statements in the document include those relating to the expected duration of the contract, the approximate gross revenues arising from the contract and the percentage of revenues relating to the purchase of materials. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are market and general economic conditions, and the fact that the contract relates to non-automotive assembly and the risk factors detailed from time to time in the Company's periodic reports filed with the Canadian securities regulatory authorities and on SEDAR at www.sedar.com. Readers are cautioned not to rely on forward-looking statements. Except as required under continuous disclosure obligations, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Automodular does not provide financial outlooks.

 

https://www.marketwire.com/press-release/automodular-announces-contract-award-in-the-renewable-energy-industry-tsx-am-1603746.htm

Bullboard Posts